CARLOS DEL RIO: Open Payments
NPI 1285608398 · DRACUT, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$514 in 25 payments from 9 companies in 2025. Trend: 2023 $259 · 2024 $721 · 2025 $514
Food & beverage: $514
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $121 |
| PFIZER INC. | 4 | $84 |
| ABBVIE INC. | 4 | $74 |
| Lilly USA, LLC | 3 | $69 |
| Otsuka America Pharmaceutical, Inc. | 3 | $61 |
| Currax Pharmaceuticals LLC | 2 | $32 |
| Astellas Pharma US Inc | 1 | $31 |
| Novo Nordisk Inc | 1 | $24 |
| Exact Sciences Corporation | 1 | $17 |
Products named: PREVNAR 20, BREZTRI, VRAYLAR, JARDIANCE, REXULTI, AIRSUPRA, CONTRAVE, Veozah.
Industry payments across MA — which companies pay providers there.
